Synthesis of Medicinally Relevant Thiazolyl Aryl Ketones Under Mild Conditions by Gardner, Danielle M.
University of Arkansas, Fayetteville
ScholarWorks@UARK
Health, Human Performance and Recreation
Undergraduate Honors Theses Health, Human Performance and Recreation
12-2015
Synthesis of Medicinally Relevant Thiazolyl Aryl
Ketones Under Mild Conditions
Danielle M. Gardner
dmgardne
Follow this and additional works at: https://scholarworks.uark.edu/hhpruht
Part of the Heterocyclic Compounds Commons, Medicinal and Pharmaceutical Chemistry
Commons, and the Organic Chemistry Commons
This Thesis is brought to you for free and open access by the Health, Human Performance and Recreation at ScholarWorks@UARK. It has been
accepted for inclusion in Health, Human Performance and Recreation Undergraduate Honors Theses by an authorized administrator of
ScholarWorks@UARK. For more information, please contact ccmiddle@uark.edu.
Recommended Citation
Gardner, Danielle M., "Synthesis of Medicinally Relevant Thiazolyl Aryl Ketones Under Mild Conditions" (2015). Health, Human
Performance and Recreation Undergraduate Honors Theses. 29.
https://scholarworks.uark.edu/hhpruht/29







Synthesis of Medicinally Relevant Thiazolyl Aryl Ketones Under Mild Conditions 
Danielle Gardner 



















Purpose: The growing amount of clinical resistance observed in current antifungal drugs and in 
anti-HIV pharmaceuticals is a concern in the medical community. The purpose of this study is to 
develop a mild synthetic process for biomedically relevant thiazolyl aryl ketones that can be used 
to develop antifungal and anti-HIV drugs. We hypothesized that the proposed synthetic 
technique would be more efficient, produce fewer unwanted byproducts, and be more tolerant of 
functional groups than existing methods.  
Methods: Prior to each of the ketone reactions, the necessary salt was synthesized by mixing 
thiazole and 9-bromofluorene neat in a reaction tube heated to 85 C. The reaction was 
monitored for the disappearance of 9-bromofluorene, at which point the heating was stopped and 
the solid product was triturated to remove impurities and characterized using 1H NMR analysis. 
For each of the various ketone reactions, the aldehyde and base were added to a reaction tube and 
heated to 60 C. Once heated, a solution of the salt (3-fluorenylthiazole) was mixed with the 
solvent, either methanol or THF, and was added dropwise via syringe. Conversion of the 
aldehyde to the ketone product was monitored by thin layer chromatography (TLC). The product 
ketone was purified using column chromatography and analyzed for purity by 1H NMR 
spectroscopy. This study was the repeated for each of the chosen aldehydes. The preparation of 
thiazolyl salicyl ketone was further analyzed for solvent effects by the introduction of 5% and 
10% water, respectively, using otherwise identical reaction conditions. In these reactions, the 
ketone was isolated using preparative TLC and gravity filtration to separate the silica gel from 
the desired product. If the ketone was produced after the addition of water, then the reaction may 
be able to be conducted without the use of anhydrous methanol solvent. Instead, methanol 
bought in bulk could be substituted and the cost of production would be substantially reduced. 
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Results: The 3-fluorenylthiazol salt was produced in 91% yield. The yields for the thiazolyl 
phenyl ketone, thiazolyl 4-fluorophenyl ketone, and the thiazolyl salicyl ketone were 11%, 50%, 
and 55% yield respectively. Production of thiazolyl salicyl ketone with the addition of 5% water 
into the solvent produced the ketone with 11% yield. Production of thiazolyl salicyl ketone with 
the addition of 10% water into the solvent produced a ketone with 13% yield in trial 1 and 56% 
yield in trial 2.  
Discussion: The study found that the two-step synthesis method was successful in producing the 
desired ketones. These findings suggest that this reaction mechanism could be further optimized 
to increase reaction yield in order to produce medicinally relevant ketones under mild conditions. 
Also, upon the addition of water to the solvent, the thiazolyl salicyl ketone was able to be 
produced in moderate yields in one trial. In this particular trial, salt and salicylaldehyde were 
added before the solvent and the base suggesting the order that reagents were added affected the 
percent yield of the ketone. The success of the trial provides promising results that suggest the 
synthetic method could be conducted without the use of anhydrous methanol thereby decreasing 
the cost of synthesis by utilizing water in replacement for methanol. Also, substituting water for 
methanol would provide a safety advantage if enough methanol is replaced so that the solvent is 
no longer flammable. Overall, the results provide the conclusion that the synthetic technique 










 Azoles are five-membered aromatic heterocyclic rings that contain at least one nitrogen 
atom along with at least one additional non-carbon atom including nitrogen, sulfur, or oxygen 
(Sheehan et. al., 1999). These common structures are extremely useful and have many industrial 
and pharmaceutical applications. Heterocyclic compounds have been used in the synthesis of 
dyes, pesticides, herbicides, and most important for this study, the sub-class of azoles have been 
used in the production of drugs with various antifungal and anti-human immunodeficiency virus 
(HIV) properties (Dua et.al., 2011). In 2011, it was estimated that 90% of new drugs contain a 
heterocyclic system (Dua et.al.). The interest in using these compounds, and azoles specifically, 
lies in their ability to participate in or hinder biochemical reactions in the body (Dua et. al., 
2011). Though the mechanism of action is not specific to azoles, these compounds exert their 
effects by changing the three-dimensional conformation of proteins altering their effects on the 
body’s tissues or inhibiting their action (Nelson et. al., 2014). This project focuses on the 
production of thiazolyl ketones in a mild and efficient manner. Due to the medicinal properties of 
azole containing compounds, an improved synthesis is particularly attractive. 
 
AntiFungal Properties: The mortality rate associated with invasive fungal infections, especially 
in immunocompromised patients, is a growing concern for the medical community (Badali et. 
al., 2013). A deficient immune system may allow certain opportunistic fungi to become life 
threatening in immune impaired patients. These at-risk patients include those suffering from 
conditions such as HIV, cancer, any undergoing cytotoxic or immunosuppressive therapies, 
transplant recipients, and those with breaks in skin or mucosal barriers (Pagniez et. al., 2002). 
The severity of fungal infections in these patients has made it more important to develop new 
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antifungal agents that are efficiently synthesized while still effective in their inhibitory affect on 
fungi. Current treatment methods are proving inadequate as fungal resistance to therapies are 
growing, furthering the need for improved, more numerous antifungal agents (Yilmaz et. al., 
2013). In study analyzing FDA approvals of compounds with pharmaceutical targets, the number 
of approvals per year has decreased 75% from its peak in 1996, and only 11.7% of these current 
approvals target fungal species (Kinch et. al., 2014). These statistics show that it is vital to 
produce antifungal compounds that overcome resistance.  
 Drugs such as fluconazole and clotrimazole, (Figure 1), are common azole containing 
medications used to target the synthesis of an essential fungal membrane component, ergosterol 
(Nelson et. al., 2014). They inhibit the cytochrome 𝑃450 enzyme 14-demethylase, thereby 
preventing the conversion of lanosterol to ergosterol  (Nelson et. al., 2014). Ergosterol is a vital 
part of the plasma membrane structure of a fungal cell and contributes to membrane fluidity 
much like cholesterol does to mammalian membranes. A decrease in the production of ergosterol 
leads to a decline in membrane integrity, a leak of cytoplasmic components, and ultimately 
affects the growth and reproduction of the fungal cell (Nelson et. al., 2014). A promising 
thiazolyl antifungal agent, abafungin, (Figure 1) inhibits the enzyme sterol-C-24-transferase, 
affecting ergosterol synthesis and membrane integrity. Abafungin also seems to have some direct 
effects on the plasma membrane, possibly through interaction with specific phospholipids, 
although the exact mechanism of action still requires further study (Borelli et.al., 2008). 
Abafungin’s multiple modes of action make the drug less susceptible to the development of 
fungal resistance to its properties.  
 Each of these compounds have mechanism that capitalize on inhibiting the production of 
vital fungal membrane proteins thereby causing a decline in membrane integrity in the overall 
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fungal cell population. This study explores the synthesis of molecular entities that are 
intermediates in the production of pharmaceuticals compounds with these antifungal benefits.  
1   2  3  
Figure 1. The molecular structures of Clotrimazole, (1) Fluconazole (2), and Abafungin (3). 
  
Uses as a Reverse Transcriptase Inhibitor: Treatment of HIV has dramatically improved in the 
last twenty years after the implementation of combination therapy, whereby HIV patients take 
two or more anti-HIV drugs together (Romines et. al., 2006). Nonnucleoside reverse 
transcriptase inhibitors (NNRTI’s) have been important to this line of therapy due to their ability 
to allosterically bind to aspartate and other catalytic residues of the reverse transcriptase active 
site, preventing it from converting viral RNA into DNA (Gerwurz et. al., 2004). Therefore, 
NNRTI’s interaction with reverse transcriptase blocks harmful genetic information from being 
incorporated into the host cell’s genome. Though the use of NNRTI’s have been demonstrated as 
efficient in fighting HIV, certain point mutations that affect bases that code for amino acids near 
the drug binding pocket are associated with the development of clinical resistance to these drugs. 
In a study of first-time anti-retroviral treatments in patients from 44 U.S. cities, nearly one-third 
of participants had a decreased therapeutic response to all currently used NNRTI’s and 18% had 
a decreased therapeutic response to at least one NNRTI (Romines et. al., 2006). Due to an 
increasing amount of resistance, it is important to identify compounds that can be used as 
NNRTI’s and that prove efficacious against resistant HIV strains. A promising potential template 
for NNRTI’s are phenyl heteroaryl ketones similar to those produced in this study. These 
SYNTHESIS OF MEDICINALLY RELEVANT KETONES 
 
7 
compounds and those similar were found to have excellent potency in vitro to mutants that were 
resistant to other prominent NNRTI’s such as nevirapine and efavirenz (Romines et. al., 2006). 
In 2001, a thiazolyl aryl ketone compound and benzophenone, seen in (Figure 2), was patented 
due to its inhibitory affect on reverse transcriptase (Andrews et. al., 2001). When used as 
NNRTI’s, the relevance of these compounds could increase the receptivity to treatment in 
otherwise resistant strains of HIV. Overall, thiazolyl compounds have a variety of medicinal 
uses, and research on these compounds will prove vital in the progression of treatment for 
diseases in this area, as well as the previously discussed treatment of fungal infections.  
1. 2.  
Figure 2. The molecular structures of a patented benzophenone (1) and a thiazolyl compound (2) 
used as an inhibitor of reverse transcriptase.    
Previous Methods of Synthesis: Thiazolyl ketones are traditionally synthesized in harsh 
conditions as in (Scheme 1) by utilizing a Grignard reagent, an organolithium compound, or a 
Weinreb Amide, whereas the project I conducted focuses on the synthesis of thiazolyl ketones 
under less hazardous conditions and a novel mechanism. Under non-mild conditions, this type of 
reaction can be carried out via a Grignard reagent, an aryl-magnesium halide, or an 
organolithium compound to form secondary alcohols which can then be deprotonated using an 
oxidizing agent (Organometallic chemistry,” 2013).  Potassium dichromate, the oxidation agent 
used in (Scheme 2), is extremely toxic and a known carcinogen. Producing the ketones without 
the use of harmful reagents is desirable in order to provide the best laboratory safety during 
production. Another common issue with this method is the over-addition of the Grignard reagent 
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resulting in the formation of tertiary alcohols even with carefully controlled conditions lowering 
the efficiency of this synthesis method. To combat this, an alternative synthesis route uses a 
Weinreb Amide along with a Grignard reagent to produce two subsequent nucleophilic reactions 
to yield the ketone (Scheme 1). Though this method does not have problems with over-addition, 
reactions with Grignard reagents are very temperamental due to their nature to react violently 
with water and the requirement that they be conducted at very low temperatures. Also, greater 
than 2 equivalents of the nucleophilic reagent are needed to produce substantial results (Liu et. 
al., 2002). Finally, there is risk that the leaving group from the Weinreb Amide could 
deprotonate a hydrogen-containing substituent group, for example the hydroxyl group in 
salicylaldehyde, before the nucleophilic between the amide and aldehyde therefore creating an 
unwanted side product. The purpose of this study is to develop a mild synthetic process of 
biomedically relevant thiazolyl aryl ketones that would be more efficient, produce fewer 
unwanted byproducts, and more tolerant of functional groups than existing methods. 
 
Scheme 1. Production of ketones using a Grignard reagent followed by oxidation of the alcohol, 
and using and an alternative route using a Weinreb Amide with a Grignard reagent.  
 In this study, thiazolyl ketones were synthesized in two steps by first producing a salt, 
then by reacting the created salt with various aldehydes. The ketone products were produced 
using benzylic aldehydes of various levels of nucleophilicity using: benzaldehyde, 
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salicylaldehyde, 3-pyridinecarboxylaldehyde, 4-fluorobenzaldehyde, and with ortho-
tolualdehyde. The mechanism is believed to occur via radical intermediates and can be seen in 
(Scheme 2). 




Scheme 2. (A) Salt Formation (B) Proposed mechanism for the mild synthesis of thiazolyl 














Salt Formation: In order to create the necessary salt for the process, 9-bromofluorene and 
thiazole were mixed in order to produce 3-fluorenylthiazole. 9-bromofluorene was chosen due to 
its ability to produce a stable radical intermediate and is the limiting reagent. Both reactants were 
mixed together neat in a pressure tube at room temperature. The tube was capped and heated to 
85 𝑜C. The mixture was then monitored for the appearance of a solid by crude NMR to see the 
disappearance of the limiting reagent. Once appeared, the solid product was triturated with 
diethyl ether to remove any soluble organic impurities. The remaining product was dried using a 
vacuum pump for 2 hours. 𝐻1  NMR spectroscopy was used to confirm that the salt has been 
formed.  
Ketone Synthesis: For the formation of the final ketone product, one of the various aldehydes 
identified as reagents in the study and 1,8-diazabicycloundec-7-ene (DBU) were added neat to a 
reaction tube. The tube was capped and heated to 60 C. Once heated, a solution of the salt and 
methanol was added to the aldehyde-containing reaction tube dropwise via syringe. The reaction 
tube was monitored periodically with thin-layer chromatography (TLC) for the conversion of 
aldehyde to the ketone product.  
Purification of the Ketone-Containing Product: Column chromatography was performed to 
isolate the ketone beginning with a 1:99 ethyl acetate: hexane solvent and incrementally 
increasing in polarity as each fraction of reaction product was collected. Each fraction collected 
from the column will be characterized using TLC analysis in 10:90 ethyl acetate: hexane. Using 
this evaluation, the product-containing layer was identified and isolated. The product solution 
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was lastly concentrated using the rotary evaporator then dried using the vacuum pump for at least 
24 hours.  
Final Ketone Product Analysis: The final dried ketone product was analyzed by using 1H NMR 
spectroscopy as well as a calculation of percent yield to confirm this method’s efficiency. The 
study will then be repeated for each of the chosen aldehydes. 
Further Analysis of the Effects of Polarity in the Solvent on the Formation of Thiazolyl Salicyl 
Ketone: The same synthesis method as described above with slightly different conditions was 
conducted to produce the salicylaldehyde containing ketone. In this portion of the study, 
salicylaldehyde and 1,8-diazabicycloundec (DBU) were added neat to the reaction tube. The 
solution was capped and heated to 60 C. Once heated, the solution of the salt, 3-
fluorenylthiazole, and methanol solvent solution containing 10% water was added to the reaction 
tube. The introduction of water into the solvent added a greater amount of polarity to the reaction 
environment and the effects were evaluated.  
 Another trial with 10% water was repeated manipulating the reaction conditions in order 
to evaluate if this would increase the product’s percent yield. In this case, the salt and 
salicylaldehyde were first added to the reaction tube and heated to 60 C. Then, the solvent, 
again 10% water and methanol, was added followed by the DBU base. The reaction progression 
was monitored using TLC analysis in order to determine the formation of the ketone product. 
Lastly, the reaction was then repeated using 5% water. The same methods were used to 
conduct this reaction as in the second 10% reaction. The salt and the salicylaldehyde were first 
added to the reaction tube and heated to 60 C. Then, the solvent, again 5% water and methanol, 
was added followed by the DBU base.  
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 In order to isolate the ketones, each of the reactions ran in 10% water and 5% water was 
isolated through a preparative TLC. The ketone containing band, yellow in color and usually 
near the middle of the TLC plate, was collected one along with the silica gel in that band of the 
plate. The product band was separated from the silica gel using gravity filtration and 
dichloromethane as the solvent. In each of the water-containing reactions these purification 
techniques were used. All of the collected products were concentrated using the rotary 
evaporator and dried on the vacuum pump for 24 hours. The reaction yield was calculated and 




















 After subjecting the 9-bromofluorene and thiazole to reaction conditions, the 3-
fluorenylthiazole salt (1) was produced a white solid obtained in a 91% yield. The 1H NMR 
signals observed were at 7.33 (singlet, 1H), 7.42 (triplet, 2H), 7.60 (multiplet, 4H), 8.05 
(multiplet, 3H), 8.32 (doublet, 1H), and 10.63 (singlet, 1H) ppm. The reaction with benzaldehyde 
and the previously produced salt resulted in a mixture of products. The desired product was 
isolated from the filtrate via column chromatography, and a yellow compound confirmed to be 
the thiazolyl phenyl ketone (2) isolated in 11% yield. The 1H NMR signals confirmed the 
formation of the product and were observed at 7.56 (triplet, 2H), 7.67 (triplet, 1H), 7.75 (doublet, 
1H), 8.13 (doublet, 1H), 8.51 (doublet, 2H). The ketone-forming reaction was repeated with 4-
fluorophenyl ketone as the chosen aldehyde. The 4-fluorophenyl ketone (3) was isolated using 
column chromotography in 50% yield. The 1H NMR signals confirmed the formation of the 
product and were observed at 7.04 (multiplet, 1H), 7.25 (multiplet, 2H), 7.40 (multiplet, 2H), 
7.74 (multiplet, 1H). Again, a reaction was conducted with salicylaldehyde and the 3-
fluorenylthiazole salt to produce the thiazolyl salicyl ketone (4), a yellow solid, with 55% yield. 
The 1H NMR signals confirmed the formation of the product and were observed at 7.05 
(multiplet, 2H), 7.53 (triplet, 1H), 7.71 (doublet, 1H), 8.14 (doublet, 1H), 9.19 (doublet, 1H), 
12.18 (singlet, 1H). Reactions with the aldehydes 3-pyridinecarboxylaldehyde and with ortho-
tolualdehyde were conducted. The reaction resulted in complex compound mixtures that were 
unable to be isolated from each other during column chromatography and the 1H NMR did not 
produce clean compound results.  
 The reaction with salicylaldehyde was further analyzed upon the addition of water to the 
solvent. The reaction was conducted with the addition of 5% water into methanol and the 
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thiazolyl salicyl ketone (5) was isolated via preparative TLC with 11% yield. The 1H NMR 
signals confirmed the formation of the product and were observed at 7.05 (multiplet, 2H), 7.55 
(triplet, 1H), 7.79 (doublet, 1H), 8.15 (doublet, 1H), 9.21 (doublet, 1H), 12.17 (singlet, 1H). The 
reaction was repeated with increasing the amount of water in the reaction environment.  
The first trial of the reaction with 10% water produced thiazolyl salicyl ketone (6), a 
yellow compound, was isolated via preparative TLC with a 13% yield. The 1H NMR signals 
confirmed the formation of the product and were observed at 7.04 (multiplet, 2H), 7.58 (triplet, 
1H), 7.80 (doublet, 1H), 8.15 (doublet, 1H), 9.21 (doublet, 1H), 12.19 (singlet, 1H). These were 
reasonably the same signals observed in the previous reaction so the product was confirmed to be 
produced. To test whether the reaction yield could be increased, production of the thiazolyl 
salicyl ketone (7) was repeated after manipulating the order that each of the reagents were added 
to the reaction tube. After isolating the reaction compound via preparative TLC, the reaction 
yield was 56%. The 1H NMR signals confirmed the formation of the product and were observed 
at at 7.04 (multiplet, 2H), 7.52 (triplet, 1H), 7.76 (doublet, 1H), 8.15 (doublet, 1H), 9.17 
(doublet, 1H), 12.20 (singlet, 1H). An almost identical 1H NMR to those previously observed for 
the thiazolyl salicyl ketone increased our confidence that the ketone was formed in good yield. A 
summary of the ketones produced and their various yields can be seen (Figure 3).  




Figure 3. The figure shows the various compounds produced in the study, including the reactant 





















 The purpose of this study was to analyze a two-step synthetic technique for producing 
thiazolyl aryl ketones. The main findings of the study were that this method was successful in the 
production of ketones using aldehyde reactants of various levels of nucleophilicity with moderate 
yields. Further analysis of the synthetic method provided promising data to show that water 
could also be introduced into the solvent and the reaction could still proceed again with moderate 
yields. In the first step of the method, the production of the salt proved to deliver good yields 
with easily reproducible methods along with the minimization of solvent waste. The results 
showed that the highest yields for this reaction were in the production of the 4-fluorophenyl 
ketone and the thiazolyl salicyl ketone, and lower in the production of the thiazolyl phenyl 
ketone. One explanation for the much lower yield of the thiazolyl phenyl ketone is the possibility 
of rearrangement products. In another study conducted by Ayinuola, a reaction with the 3-
fluorenylthiazole salt with benzaldehyde under similar conditions produced a 20% yield and 
three rearrangement products (2015). In contrast to the study by Ayinuola, the ketone was only 
being isolated in this study, and the possibility of the appearance of rearrangements was not 
analyzed. These possible rearrangement products could be the subject of further study in order to 
determine their impact of reaction yield. Previously identified rearrangement possibilities can be 
seen in (Figure 4) (Ayinuola, 2015). Also, reactions with aldehydes 3-pyridinecarboxylaldehyde 
and ortho-tolualdehyde resulted in complex reaction mixtures that did not result in a clear ketone 
band in column chromatography to be isolated. As compared to a synthesis method using a 
Weinreb Amide, which could deprotonate the hydrogen in salicylaldehyde forming an unwanted 
product, this synthesis method can combat this unnecessary byproducts. 




Figure 4. The figure shows possible rearrangement products that could have formed and caused 
the thiazolyl benzyl ketone produced in the study to have a lower yield than expected (Ayinuola, 
2015).  
 
 Finally, the introduction of water into the solvent produced interesting results. In the first 
trial, the salicylaldehyde and the base were added before the salt and solvent thereby producing 
much lower yields than in Trial 2. It seems that 10% water solvent yields were optimized only 
when the salt and salicylaldehyde were added before the solvent and the base. These reaction 
conditions were repeated with 5% water and again produced a low yield of ketone. The 
hypothesis was that with a lower amount of water, the reaction would behave more like the trial 
with no water and would produce closer to moderate yields. This was not observed, and more 
experimentation needs to be done in order to optimize conditions for a reaction with water and to 
consider how the introduction of water into the reaction environment affects the ketone 
formation. Even so, one successful trial after adding water to the solvent provides promising 
resulting that the method may be able to be conducted while substituting methanol for water. By 
substituting water for substantial amounts of methanol, the cost of synthesis could be 
dramatically decreased. The success of the 10% trial provides promising data to suggest that 
water could be substituted for methanol without dramatically effecting the reaction. Along with a 
cost benefit, substituting water for methanol could provide a safety advantage if enough water 
was added so that the solvent is no longer flammable. An increase in safety and cost decrease 
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would prove beneficial with more widespread production of these compounds for their ultimate 
pharmaceutical uses, and would make this synthetic technique more desirable for commercial 
uses.  
Limitations 
 A limitation in this study is human error when isolating the ketone product. In 
purification by column chromatography and preparative TLC, the remaining aldehyde band and 
the product band are extremely close together. It takes precision to isolate the band from the 
remaining reactants. This involves manipulation of solvent polarity when conducting column 



















 The purpose of this study was to determine if the two-step proposed synthetic 
technique was successful in producing medicinally relevant thiazolyl aryl ketones. We found that 
while the synthesis technique is successful in producing the desired ketones, more research needs 
to be done in order to optimize the reaction yield. Still, this study helped to analyze a technique 
that minimizes solvent waste and is conducted under less harmful conditions than previously 
utilized. These methods could potentially make the production of thiazolyl ketones a more 
effective synthetic process that produces fewer unwanted byproducts and is more tolerant of 
functional groups than existing methods. Also, the success of a trial after the addition of water 
into the solvent provides promising results suggesting that the reaction could be conducted while 
substituting water for methanol. This could make the production of these pharmaceutical 
intermediates more suited for commercial production due to reduced production costs and an 
added safety advantage. Overall, the results provide the conclusion that the synthetic technique 
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